A new meta-analysis suggests that administering an antibiotic injection during cataract surgery is associated with a lower risk of endophthalmitis, a rare but serious eye infection, according to a report by Eyewire+ published Monday.
The findings, summarized by Eyewire+, point to a potential preventive benefit from the injection. Endophthalmitis can cause severe inflammation inside the eye and, in some cases, lead to permanent vision loss, making infection control a key concern for surgeons.
The analysis pooled data from multiple studies to compare outcomes for patients who received the antibiotic injection against those who did not. According to the report, the results showed a statistically meaningful reduction in infection rates among the injection group, though the underlying article did not specify the exact antibiotic used or the size of the risk reduction.
Cataract surgery is one of the most commonly performed procedures worldwide, and even low infection rates translate into a significant number of cases annually. Surgeons already use various preventive measures, including topical antiseptics and sterile technique, but the role of prophylactic antibiotics remains an area of active debate. This meta-analysis adds weight to the argument for routine injection, but it does not establish a universal standard of care.
The report from Eyewire+ did not include details on patient demographics, follow-up duration, or potential side effects of the injection. Those gaps mean the findings should be interpreted cautiously until full peer-reviewed data are available.
What to watch next: Whether ophthalmic societies update their clinical guidelines to recommend this injection as a standard part of cataract procedures.
